Solid Biosciences Inc (SLDB)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.30 -0.37 (-10.08%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.33 +0.03 (+0.91%) 16:05 ET
for Fri, Apr 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -124,697 | -96,015 | -85,981 | -72,188 | -88,290 |
Depreciation Amortization | -1,137 | 173 | 2,641 | 4,081 | 3,902 |
Accounts receivable | N/A | N/A | 110 | -110 | N/A |
Accounts payable and accrued liabilities | 2,205 | -764 | -5,246 | 1,209 | -3,431 |
Other Working Capital | 2,850 | -8,868 | -3,689 | -23,041 | 16,160 |
Other Operating Activity | 20,767 | 11,294 | -5,812 | 12,285 | 15,060 |
Operating Cash Flow | $-100,012 | $-94,180 | $-97,977 | $-77,764 | $-56,599 |
Cash Flows From Investing Activities | |||||
Change In Deposits | -15,437 | 11,204 | 30,049 | -89,805 | 7,499 |
PPE Investments | -649 | -1,515 | -2,415 | -1,281 | -899 |
Net Acquisitions | N/A | N/A | 31,523 | N/A | N/A |
Investing Cash Flow | $-16,086 | $9,689 | $59,157 | $-91,086 | $6,600 |
Cash Flows From Financing Activities | |||||
Change In Short Term Borrowing | N/A | N/A | 2,143 | N/A | N/A |
Debt Repayment | -473 | N/A | N/A | N/A | N/A |
Common Stock Issued | 127,684 | 2,974 | 72,573 | 134,919 | 132,490 |
Other Financing Activity | -4,774 | 148 | 115 | 66 | -3,790 |
Financing Cash Flow | $122,437 | $3,122 | $74,831 | $134,985 | $128,700 |
Beginning Cash Position | 75,848 | 157,217 | 121,206 | 155,071 | 76,370 |
End Cash Position | 82,187 | 75,848 | 157,217 | 121,206 | 155,071 |
Net Cash Flow | $6,339 | $-81,369 | $36,011 | $-33,865 | $78,701 |
Free Cash Flow | |||||
Operating Cash Flow | -100,012 | -94,180 | -97,977 | -77,764 | -56,599 |
Capital Expenditure | -654 | -1,515 | -3,015 | -1,281 | -899 |
Free Cash Flow | -100,666 | -95,695 | -100,992 | -79,045 | -57,498 |